Palliative Radiation Therapy
Palliative Radiation Therapy
Radiation
Radiation describes the way energy moves from one place to another.
Sometimes this is in the form of particles such as protons, while other times it is in the
form of waves like x-rays or visible light. The various types of radiation are grouped
according to how much energy they contain. Low energy radiation, like radio waves and
heat, is known as non-ionizing radiation. High energy radiation, such as ultraviolet (UV)
light from the sun and x-rays, is known as ionizing radiation because it has enough
energy to break chemical bonds and knock electrons (negatively charged particles) out
of atoms. When these changes take place in cells, it can sometimes cause enough
damage to kill the cells. As a result, such high-energy x-rays or other particles can be
used to destroy cancer cells in a treatment called radiation therapy.
2. Radiation as therapy
Doctors known as radiation oncologists oversee radiation therapy, which usually
consists of a specific number of treatments given over a set period of time. The goal of
this treatment is to destroy cancer cells without harming nearby healthy tissue.
Radiation therapy may be used as the main treatment or as an adjuvant therapy
(treatment given after the main treatment to target any potential remaining cancer cells).
Radiation therapy can also be used to shrink tumors and reduce pressure, pain, and
other symptoms of cancer (called palliative radiation therapy) when it is not possible to
completely eliminate the disease.
More than half of all people with cancer receive some type of radiation therapy.
For some cancers, radiation therapy alone is an effective treatment; however, other
types of cancer respond best to combination treatment approaches that may include
radiation plus surgery, chemotherapy, or immunotherapy.
3.3 Types of radiation therapy
3.3.1 External-beam radiation therapy.
This is the most common type of radiation treatment, and it involves giving
radiation from a machine located outside the body. It can treat large areas of the body, if
necessary. The machine typically used to create the radiation beam is called a linear
accelerator or linac. Computers with special software are used to adjust the size and
shape of the beam and to direct it to target the tumor while avoiding the healthy tissue
that surrounds the cancer cells. External-beam radiation therapy does not make you
radioactive.
3.3.1.1 Types of external-beam radiation therapy include:
damaging healthy tissue. Studies have shown that 3D-CRT can lower the risk of
complications and side effects, such as damage to the salivary glands (which can
cause dry mouth), when people with head and neck cancer are treated with
radiation therapy.
Intensity modulated radiation therapy (IMRT): This treatment better directs the
radiation dose at the tumor than 3D-CRT by precisely modulating (varying) the
intensity of the beam under strict computer guidance. (The positioning of the
beam occurs during a specialized planning process.) Because of the modulation
of the beam intensity and the special planning computers, IMRT protects healthy
tissues from radiation better than 3D-CRT.
Proton beam therapy: This treatment uses protons, rather than x-rays, to treat
some cancers. Protons are parts of atoms that at high energy can destroy cancer
cells. Researchers have found that directing protons at a tumor decreases the
amount of radiation delivered to surrounding healthy tissue, reducing the damage
to that tissue. Because this therapy is relatively new and requires highly
specialized equipment, it is not available at every medical center. The potential
benefits of proton therapy compared to IMRT have not been established for some
cancers, such as prostate cancer. Learn more about proton therapy
used for more time, the patient remains in a private room while the implants are in place
to limit others exposure to the radiation.
3.3.3 Other treatment options
Intraoperative radiation therapy (IORT). Radiation therapy can be delivered
directly to the tumor during surgery, either as external-beam radiation therapy or as
internal radiation therapy. This technique allows the surgeon to move healthy tissue out
of the way before radiation therapy occurs, and it may be helpful when vital (lifesustaining) organs are located very close to the tumor.
Systemic radiation therapy. Systemic (whole body) radiation therapy uses
radioactive materials, such as iodine 131 or strontium 89, that can be taken by mouth or
injected into the body to target cancer cells. These radioactive materials leave the body
through saliva, sweat, and urine, making these fluids radioactive. Additional safety
measures must be taken to protect people who come in close contact with the patient.
For more information, see the Safety for the patient and family section below.
Radioimmunotherapy. A type of systemic therapy, this treatment uses
monoclonal antibodies to deliver radiation directly to cancer cells. Monoclonal
antibodies are laboratory-made proteins designed to attach to specific factors only
found in cancer cells. By attaching radioactive molecules to these antibodies in a
laboratory, they can deliver low doses of radiation directly to the tumor while leaving
noncancerous cells alone. Examples of these radioactive molecules include
ibritumomab (Zevalin) and tositumomab (Bexxar).
Radiosensitizers and radioprotectors. Researchers are studying substances
that help radiation better destroy tumors (radiosensitizers) and those that better protect
healthy tissues near the area being treated (radioprotectors). Examples of
radiosensitizers include fluorouracil (5-FU) and cisplatin (Platinol), while amifostine
(Ethyol) is a radioprotector.
Safety for the patient and family
During external-beam radiation therapy, the patient does not become radioactive;
the radiation remains in the treatment room. However, because internal radiation
therapy causes the patient to emit radiation, a number of safety measures are
necessary.
While the implant is in place, women who are pregnant and children younger
than 18 should not visit the person receiving treatment. Other visitors should sit at least
six feet from the patients bed and limit their stay to 30 minutes or less each day.
Permanent implants remain radioactive after the patient is discharged from the hospital,
so he or she should not have close (less than six feet) or lengthy (more than five
minutes) contact with women who are pregnant and children for two months.
With systemic radiation therapy, safety precautions must be followed for the first few
days after treatment. The risk of radiation exposure to family and friends can be
minimized using the following precautions:
of your radiation treatment so that you can have it for future reference. As your body
heals, you will need fewer follow-up appointments.
5.1 Radioactive iodine (radioiodine) therapy for thyroid cancer
Your thyroid gland absorbs nearly all of the iodine in your body. When radioactive
iodine (RAI), also known as I-131, is taken into the body in liquid or capsule form, it
concentrates in thyroid cells. The radiation can destroy the thyroid gland and any other
thyroid cells (including cancer cells) that take up iodine, with little effect on the rest of
your body. (The radiation dose used here is much stronger than the one used in
radioiodine scans, which were described in How is thyroid cancer diagnosed?)
This treatment can be used to ablate (destroy) any thyroid tissue not removed by
surgery or to treat some types of thyroid cancer that have spread to lymph nodes and
other parts of the body.
Radioactive iodine therapy improves the survival rate of patients with papillary or
follicular thyroid cancer (differentiated thyroid cancer) that has spread to the neck or
other body parts, and this treatment is now standard practice in such cases. But the
benefits of RAI therapy are less clear for patients with small cancers of the thyroid gland
that do not seem to have spread, which can often be removed completely with surgery.
Discuss your risks and benefits of RAI therapy with your doctor. Radioactive iodine
therapy cannot be used to treat anaplastic (undifferentiated) and medullary thyroid
carcinomas because these types of cancer do not take up iodine.
For RAI therapy to be most effective, patients must have high levels of thyroidstimulating hormone (TSH or thyrotropin) in the blood. This substance stimulates thyroid
tissue (and cancer cells) to take up radioactive iodine. If the thyroid has been removed,
one way to raise TSH levels is to not take thyroid hormone pills for several weeks. This
causes very low thyroid hormone levels (a condition known as hypothyroidism), which in
turn causes the pituitary gland to release more TSH. This intentional hypothyroidism is
temporary, but it often causes symptoms like tiredness, depression, weight gain,
constipation, muscle aches, and reduced concentration. Another way to raise TSH
levels before RAI therapy is to give an injectable form of thyrotropin (Thyrogen), which
can make withholding thyroid hormone for a long period of time unnecessary. This drug
is given daily for 2 days, with the RAI on the 3rd day.
Most doctors also recommend that the patient follow a low iodine diet for 1 or 2
weeks before treatment. This means avoiding foods that contain iodized salt and red
dye #3, as well as dairy products, eggs, seafood, and soy.
References:
American Cancer Society, Inc. (2014, May 5). Understanding Radiation Therapy.
Retrieved from Cancer Org Website:
http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/radiation/und
erstandingradiationtherapyaguideforpatientsandfamilies/understanding-radiationtherapy-what-is-radiation-therapy